Surrozen Inc (SRZN)
10.15
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
10.09
-0.06
(-0.59%)
After-Hours: 20:00
Surrozen Total Assets (Quarterly): 36.72M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 36.72M |
| December 31, 2023 | 46.08M |
| September 30, 2023 | 53.97M |
| June 30, 2023 | 64.00M |
| March 31, 2023 | 74.20M |
| December 31, 2022 | 89.44M |
| Date | Value |
|---|---|
| September 30, 2022 | 91.43M |
| June 30, 2022 | 104.13M |
| March 31, 2022 | 117.66M |
| December 31, 2021 | 137.17M |
| September 30, 2021 | 150.64M |
| December 31, 2020 | 62.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
36.72M
Minimum
Mar 2024
150.64M
Maximum
Sep 2021
85.62M
Average
81.82M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 5.357M |
| Protalix BioTherapeutics Inc | 89.82M |